Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells
Kellianne M. Piell, Anna Vallarta, Ali E. Wilt, Bailey L Avila-Valdes et autres
us (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Kellianne M. Piell, Anna Vallarta, Ali E. Wilt, Bailey L Avila-Valdes et autres
us (code pays fourni par la source)
Belinda J. Petri, Kellianne M. Piell, Banrida Wahlang, Chariker Julia et autres
Background/Objectives: Long-term exposure to polychlorinated biphenyls (PCBs), including the mixture of PCBs in Aroclor1260 (Ar1260), results in metabolic dysfunction-associated steatotic liver disease (MASLD) in mice and humans. While the effects of PCBs on gene expression are well-documented using short-read RNA sequencing, the …
us (code pays fourni par la source)
Belinda J. Petri, Kellianne M. Piell, Bailey L Avila-Valdes, Christian G. Stanley et autres
The role of epitranscriptomic changes in the development of acquired endocrine therapy (ET)- resistance in estrogen receptor α (ER) expressing breast cancer (BC) is unknown. We tested the hypothesis that inhibition of METTL3, the methyltransferase responsible for the mRNA modification N-6 methyladenosine …
us (code pays fourni par la source)
Carolyn M. Klinge, Julia H. Chariker, Kellianne M. Piell, Belinda J. Petri et autres
Background/Objectives: Exposure of high-fat diet (HFD)-fed mice to polychlorinated biphenyls (PCBs) results in metabolic dysfunction-associated steatotic liver disease (MASLD) and progression to metabolic dysfunction-associated steatohepatitis (MASH). The mechanisms by which HFD diet and PCBs increase MASLD are unclear. Previously, we identified differences …
us (code pays fourni par la source)
Bart‐Jeroen Petri, B Valdés, Kellianne M. Piell, Eric Christian Rouchka et autres
Abstract Disclosure: B.J. Petri: None. B.L. Valdes: None. K.M. Piell: None. E.C. Rouchka: None. C.M. Klinge: None. Acquired resistance to endocrine therapies (ET) in patients with estrogen receptor α (ER+) breast tumors results in metastatic spread. RNA modifications including N6-methyladenosine (m6A) play …
us (code pays fourni par la source)
Bart‐Jeroen Petri, B Valdés, Kellianne M. Piell, Eric Christian Rouchka et autres
Abstract Disclosure: B.J. Petri: None. B.L. Valdes: None. K.M. Piell: None. E.C. Rouchka: None. C.M. Klinge: None. Acquired resistance to endocrine therapies (ET) in patients with estrogen receptor α (ER+) breast tumors results in metastatic spread. RNA modifications including N6-methyladenosine (m6A) play …
us (code pays fourni par la source)
Kellianne M. Piell, Claire C. Poulton, Christian G. Stanley, David J. Schultz et autres
Anacardic acid (AnAc) inhibits the growth of estrogen receptor α (ERα)-positive MCF-7 breast cancer (BC) cells and MDA-MB-231 triple-negative BC (TNBC) cells, without affecting primary breast epithelial cells. RNA sequencing (seq) and network analysis of AnAc-treated MCF-7 and MDA-MB-231 cells suggested that …
us (code pays fourni par la source)
Alec C. McDonald, Carly Warden, Jinlian Tan, Kellianne M. Piell et autres
The acidic byproducts of bacteria in plaque around orthodontic brackets contribute to white spot lesion (WSL) formation. Nitric oxide (NO) has antibacterial properties, hindering biofilm formation and inhibiting the growth of oral microbes. Materials that mimic NO release could prevent oral bacteria-related …
us (code pays fourni par la source)
Belinda J. Petri, B Valdés, Kellianne M. Piell, Eric Christian Rouchka et autres
Abstract A major limitation of current adjuvant treatments for the ~ 70% of breast cancer patients with estrogen receptor α–expressing (ER+) primary breast tumors is the development of acquired and adaptive endocrine therapy (ET) resistance and metastatic spread. Chemical modifications of transcribed …
us (code pays fourni par la source)
Kellianne M. Piell, Belinda J. Petri, Jason J. Xu, Lu Cai et autres
us (code pays fourni par la source)
Rameesa D. Syed Mohammed, Kellianne M. Piell, Muriel C. Maurer
BACKGROUND: Factor XIII (FXIII) forms covalent crosslinks across plasma and cellular substrates and has roles in hemostasis, wound healing, and bone metabolism. FXIII activity is implicated in venous thromboembolism (VTE) and is a target for developing pharmaceuticals, which requires understanding FXIII - …
us (code pays fourni par la source)
Belinda J. Petri, Kellianne M. Piell, Banrida Wahlang, Kimberly Z. Head et autres
us (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic